Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk.
about
Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patternsMultiple risk factor interventions for primary prevention of coronary heart diseaseInterventions to improve adherence to lipid lowering medicationMultiple risk factor interventions for primary prevention of coronary heart diseaseInterventions to improve adherence to lipid lowering medicationEngaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study.Cholesterol risk management: a systematic examination of the gap from evidence to practice.Interventions to improve adherence to lipid-lowering medication.Healthy People 2010: challenges, opportunities, and a call to action for America's pharmacists.Pharmacy students screening for pre-diabetes/diabetes with a validated questionnaire in community pharmacies during their experiential rotation in Alberta, Canada.Integrating a brief pharmacist intervention into practice: Osteoporosis pharmacotherapy assessmentA community pharmacy-based cardiovascular risk screening service implemented in IranPractice-based research: lessons from community pharmacist participants.[Treatment of coronary risk factors by general practitioners in Austria]Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists.The value of pharmacist involvement in a point-of-care service, walk-in lipid screening program.Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP).Long-term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: extended follow-up of the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus).Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia.Pharmacist interventions for obesity: improving treatment adherence and patient outcomes.
P2860
Q24234308-CC283B40-120B-48AE-B2C7-07E542EF5A97Q24234642-EA2A32F1-0F8B-4374-81BA-1027BF0DAF7FQ24236817-846EE650-7E7B-448B-8677-307DBE1FA260Q24243941-26CA0018-2203-4249-9E10-DF6E9E5BD306Q24245739-EF28FE0B-E3A9-486D-9ECF-C48871ADB505Q33685028-11924B6D-78FB-4614-BA13-3C1216584984Q34303364-BD4A4FDF-8DA7-4258-A1A7-43533622F70AQ34547763-31528C5B-2BD7-43EE-A475-A5CA9ADDDC91Q35906334-AF97304D-B58D-4D6E-86C3-CDC2FEDF124FQ36372089-740833CB-2AE1-4E88-960E-CF7EDBB399D2Q36596015-B8BE1648-44A7-4848-A433-49C8C33A5AE4Q38687368-B7BA105D-D589-4621-BCF0-428A8E72DBF8Q40703046-11AFB034-EC8F-4953-8C04-8C145C20E466Q43544754-D1039711-6A34-42A0-99F0-A473AE9872E8Q43605184-5458BB66-2B59-43B3-BECB-1F93351A9A6EQ43803079-3D375213-57E1-4F72-8660-26EC72661AC8Q44811925-06B0923B-3BAE-4C0D-881C-49A1E0EC1168Q46378376-AE59E6FB-ED02-48BF-BFF9-CFA1061F380DQ46435146-C0B82D36-6829-4568-97E6-3904F230238AQ49011495-2236197A-9026-4364-8166-58836E231FB2
P2860
Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Study of Cardiovascular Risk I ...... ram on serum cholesterol risk.
@en
Study of Cardiovascular Risk Intervention by Pharmacists
@nl
type
label
Study of Cardiovascular Risk I ...... ram on serum cholesterol risk.
@en
Study of Cardiovascular Risk Intervention by Pharmacists
@nl
prefLabel
Study of Cardiovascular Risk I ...... ram on serum cholesterol risk.
@en
Study of Cardiovascular Risk Intervention by Pharmacists
@nl
P2093
P2860
P356
P1476
Study of Cardiovascular Risk I ...... ram on serum cholesterol risk.
@en
P2093
J G Taylor
K B Farris
M L Ackman
R T Tsuyuki
S H Simpson
P2860
P304
P356
10.1345/APH.18380
P407
P577
1999-09-01T00:00:00Z